Dear Members and Friends,
Welcome to this edition of the Working Group Thrombosis newsletter.
I am delighted to share with you two important new Consensus Documents from the Working Group on Thrombosis, which have been recently published. Firstly, we have:
With the advent of effective coagulant therapies, the life expectancy of patients with haemophilia and other severe congenital bleeding disorders has significantly increased. This document offers advice and guidance on the approach to antithrombotic therapy when such patients develop pro-thrombotic conditions like AF and ACS.
Secondly, hot off the press, a collaboration of the Working Group on Thrombosis with the EAPCI, and published just last month:
Thrombotic and bleeding risks differ between men and women, partly due to hormonal status, but also due to differences in age, comorbidities and body size at presentation. This paper provides expert consensus to optimise antithrombotic strategies according to sex, to reduce thrombotic and bleeding risk.
Please do not forget to make space in your diaries for the next meeting of our Working Group on Thrombosis, the ESC Heart & Stroke and EuroThrombosis 2025, which will be a joint meeting between our group and the ESC Council on Stroke. The conference will take place in Milan, from 15 to 16 November 2025.
Please also submit your research and interesting clinical case reports to us – our portal is now live for submission. There will be prizes for the best clinical and research abstracts, as well as best clinical case presentations.
Stay tuned on our social media platforms
LinkedIn: https://www.linkedin.com/groups/14601551/
X (Twitter): https://x.com/ESCWGThrombosis
If you have suggestions for our Working Group activities, wish to showcase your publications, or would like to include something in future newsletters, please reach out to Christina Christersson our communications coordinator at Christina.Christersson@medsci.uu.se.
All my best wishes
Diana
